RGD-K5 FDG   Pre-treatment Post 2-dose bevacizumab Post 4-dose bevacizumab Pre-treatment Post 4-dose bevacizumab Axillary Node 10.8 4.7 (-56%) 3.5 (-68%) 1.0 0.9 (-13%) Bone met 10.1 6.5 (-36%) 4.0 (-61%) 3.5 2.0 (-43%) Hilar node L 6.7 4.8 (-29%) 3.6 (-46%) 6.3 3.9 (-38%) Mediastinal Node 5.5 3.3 (-39%) 3.7 (-32%) 4.0 2.8 (-29%) Hilar node R 4.8 4.4 (-8%) 3.4 (-29%) 3.8 4.0 (4%)

Table 1: The SUVmax of lesions that can be well identified on RGD-K5 scan of Subject-1, and the percentage reduction after treatment compared to the baseline value.